• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Atlantic Coastal Acquisition Corp. II

    9/13/24 4:01:26 PM ET
    $ACAB
    Blank Checks
    Finance
    Get the next $ACAB alert in real time by email
    DEFA14A 1 d867134ddefa14a.htm DEFA14A DEFA14A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

    (Amendment No.  )

     

     

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

     

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐

    Definitive Proxy Statement

     

    ☒

    Definitive Additional Materials

     

    ☐

    Soliciting Material Pursuant to §240.14a-12

    Atlantic Coastal Acquisition Corp. II

    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No fee required.

     

    ☐

    Fee paid previously with preliminary materials.

     

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     


    ATLANTIC COASTAL ACQUISITION CORP. II

    6 St Johns Lane, Floor 5

    New York, NY 10013

    SUPPLEMENT TO PROXY STATEMENT FOR

    THE SPECIAL MEETING OF STOCKHOLDERS

    To Be Held September 16, 2024

     

     

    Explanatory Note

    On September 4, 2024, Atlantic Coastal Acquisition Corp. II, which we refer to as “we,” “us,” “our,” “ACAB” or the “Company,” filed a definitive proxy statement, which, as supplemented, we refer to as the “Proxy Statement,” for a special meeting, which we refer to as the “Special Meeting,” of stockholders of the Company to be held at 4:30 p.m. Eastern Time on September 16, 2024. This supplement, which we refer to as this “Supplement,” to the Proxy Statement supplements the Proxy Statement as filed and should be read in conjunction with the Proxy Statement and any other additional proxy materials we have filed.

    The purpose of this Supplement is to increase the consideration to be offered to stockholders who do not redeem their shares of Series A common stock for each share that is not redeemed through the meeting date from $0.025 per month per share to $0.03 per month per share.

    THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT.

    EXCEPT AS SPECIFICALLY SUPPLEMENTED BY THE INFORMATION CONTAINED HEREIN, THIS

    SUPPLEMENT DOES NOT MODIFY ANY OTHER INFORMATION SET FORTH IN THE PROXY

    STATEMENT.

    This Supplement supplements and updates the disclosures in the Proxy Statement as follows:

     

      •  

    All references in the Proxy Statement to “$0.025” are replaced with “$0.03”; the reference in the Proxy Statement to “$11.32” is replaced with “$11.33”; the reference in the Proxy Statement to “$33,369” is replaced with “$40,043.”

    —

    Other than the changes described in this Supplement, the terms in the Proxy Statement remain as described.

    Important Information

    There are no changes to the proposals to be acted upon at the Special Meeting, which are described in the Proxy Statement, or the proxy card you previously received. Except as amended or supplemented by the information contained in this Supplement, all information set forth in the Proxy Statement continues to apply and should be considered in voting your shares.

    This Supplement and the Proxy Statement are available on the SEC’s website at www.sec.gov.

    Whether or not you intend to be present at the Special Meeting of Stockholders, we urge you to vote or submit your proxy promptly.

     

    2


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: September 13, 2024     By Order of the Board of Directors
        /s/ Shahraab Ahmad
        Shahraab Ahmad
        Chairman and Chief Executive Officer

     

    3

    Get the next $ACAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACAB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ACAB
    SEC Filings

    View All

    SEC Form NT 10-Q filed by Atlantic Coastal Acquisition Corp. II

    NT 10-Q - Abpro Holdings, Inc. (0001893219) (Filer)

    11/15/24 4:05:03 PM ET
    $ACAB
    Blank Checks
    Finance

    Atlantic Coastal Acquisition Corp. II filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Abpro Holdings, Inc. (0001893219) (Filer)

    11/13/24 5:21:02 PM ET
    $ACAB
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Atlantic Coastal Acquisition Corp. II

    25-NSE - Atlantic Coastal Acquisition Corp. II (0001893219) (Subject)

    11/12/24 4:31:03 PM ET
    $ACAB
    Blank Checks
    Finance

    $ACAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

    NEW YORK, June 13, 2024 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ:ACAB) (the "Company"), a special purpose acquisition company, announced that it had previously received written notification (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on June 3, 2024 that, because the Company had not yet filed its Quarterly Report on Form 10-Q for the three month period ended March 31, 2024 (the "10-Q") with the Securities and Exchange Commission (the "SEC"), the Company was not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1). The Notice has no immediate effect on the listing of the Company

    6/13/24 4:15:00 PM ET
    $ACAB
    Blank Checks
    Finance

    Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

    WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation ("Abpro"), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACAB), a special purpose acquisition company ("Atlantic Coastal"), today announced the filing of a registration statement on Form S-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") on January 19, 2024, which includes a preliminary proxy statement and prospectus in connection with its proposed business combination. Upon the closing of the proposed business

    1/22/24 8:00:00 AM ET
    $ACAB
    Blank Checks
    Finance

    Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. II

    Abpro is a biotechnology company specializing in the development of next-generation antibody therapies intended to improve the lives of those with life-threatening diseases. The transaction values Abpro at $725 million and will help advance Abpro's drug pipeline to clinical trials. Abpro Corporation ("Abpro"), a biotechnology company with the mission of improving the lives of those facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACAB), a special purpose acquisition corporation ("Atlantic Costal"), today announced a term sheet to enter into a definitive business combination, which was entered into o

    9/21/23 4:00:00 PM ET
    $ACAB
    Blank Checks
    Finance

    $ACAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Abpro Bio International, Inc. claimed ownership of 16,507,334 shares (SEC Form 3)

    3 - Abpro Holdings, Inc. (0001893219) (Issuer)

    11/18/24 9:00:34 PM ET
    $ACAB
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Mcdonald Ian

    3 - Abpro Holdings, Inc. (0001893219) (Issuer)

    11/18/24 8:52:41 PM ET
    $ACAB
    Blank Checks
    Finance

    Co-CEO & Chairman Suk Jin Wook (Miles) was granted 91,900 shares (SEC Form 4)

    4 - Abpro Holdings, Inc. (0001893219) (Issuer)

    11/15/24 9:34:52 PM ET
    $ACAB
    Blank Checks
    Finance

    $ACAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Atlantic Coastal Acquisition Corp. II (Amendment)

    SC 13G/A - Atlantic Coastal Acquisition Corp. II (0001893219) (Subject)

    2/7/24 1:53:24 PM ET
    $ACAB
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Atlantic Coastal Acquisition Corp. II (Amendment)

    SC 13G/A - Atlantic Coastal Acquisition Corp. II (0001893219) (Subject)

    1/19/24 4:17:41 PM ET
    $ACAB
    Blank Checks
    Finance

    SEC Form SC 13D filed by Atlantic Coastal Acquisition Corp. II

    SC 13D - Atlantic Coastal Acquisition Corp. II (0001893219) (Subject)

    4/20/23 6:01:50 AM ET
    $ACAB
    Blank Checks
    Finance